Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO1998052598) NOVEL ADMINISTRATION OF THROMBOPOIETIN
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1998/052598 International Application No.: PCT/US1998/010475
Publication Date: 26.11.1998 International Filing Date: 21.05.1998
Chapter 2 Demand Filed: 18.12.1998
IPC:
A61K 38/19 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
19
Cytokines; Lymphokines; Interferons
Applicants:
GENENTECH, INC. [US/US]; 1 DNA Way South San Francisco, CA 94080-4990, US (AllExceptUS)
COHEN, Robert, L. [US/US]; US (UsOnly)
EATON, Dan, L. [US/US]; US (UsOnly)
JONES, Andrew, J., S. [GB/US]; US (UsOnly)
JONES, Dennie, V. [US/US]; US (UsOnly)
POWELL, Michael, F. [US/US]; US (UsOnly)
SWEENEY, Theresa, D. [GB/US]; US (UsOnly)
THOMAS, Griffith, R. [US/US]; US (UsOnly)
WAGEMAKER, Gerard [NL/NL]; NL (UsOnly)
Inventors:
COHEN, Robert, L.; US
EATON, Dan, L.; US
JONES, Andrew, J., S.; US
JONES, Dennie, V.; US
POWELL, Michael, F.; US
SWEENEY, Theresa, D.; US
THOMAS, Griffith, R.; US
WAGEMAKER, Gerard; NL
Agent:
SCHWARTZ, Timothy, R. ; Genentech, Inc. 1 DNA Way South San Francisco, CA 94080-4990, US
CRIPPS, Joanna, E.; Mewburn Ellis York House 23 Kingsway London WC2B 6HP, GB
Priority Data:
08/859,76721.05.1997US
09/015,01628.01.1998US
Title (EN) NOVEL ADMINISTRATION OF THROMBOPOIETIN
(FR) NOUVEAU PROCEDE D'ADMINISTRATION DE THROMBOPOIETINE
Abstract:
(EN) Thrombopoietin materials can be administered with substantial therapeutic effect in a single or low-multiple daily administration. Reversal of thrombocytopenia is achieved by administering to a patient having or in need of such treatment a single or low-multiple daily dose of a therapeutically effective amount of a thrombopoietin.
(FR) L'invention concerne des matières de thrombopoïétine pouvant être administrées de façon à obtenir un effet sensiblement thérapeutique en une seule prise quotidienne ou en plusieurs prises à faible dose. On obtient une inversion de la thrombocytopénie en administrant à un patient atteint de cette maladie ou nécessitant un tel traitement une seule dose quotidienne ou de multiples faibles doses d'une quantité thérapeutiquement efficace d'une thrombopoïétine.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, GW, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP0983082JP2001526689 CA2288964AU1998075898